Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
Alzheimer's disease risk genes in wild-type adult zebrafish exhibit gender-specific expression changes during aging
Alzheimer disease is in part a thrombohemorrhagic disorder
Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants
Alzheimer's disease: the silver tsunami of the 21st century
Alzheimer%26apos;s disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo
Alzheimer's disease drug development based on Computer-Aided Drug Design
Alzheimer%26apos;s Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
Alzheimer's disease, menopause and the impact of the estrogenic environment
Alzheimer%26apos;s Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy
Alzheimer%26apos;s disease due to loss of function: A new synthesis of the available data
Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-beta with Regard to Potential Treatment and Prevention
Alzheimer%26apos;s disease genes and autophagy
Alzheimer's disease Advax(CpG)-adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and A beta pathological molecules
Alzheimer%26apos;s Disease Risk Genes and Lipid Regulators
Alzheimer's Disease therapeutics: current and future therapies
Alzheimer病的脑质子磁共振波谱研究
Alzheimer病杏仁核海马结构体积的MRI测量
Alzheimer病和血管性痴呆60例临床观察
Alzheimer病患者血浆中Tau蛋白与载脂蛋白E基因多态性的关系
Alzheimer's disease risk genes and the age-at-onset phenotype
Alzheimer%26apos;s Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin
Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
Alzheimer's Disease: A Light at the End of the Tunnel? Preface
Alzheimer's disease biomarkers: Correspondence between human studies and animal models
Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development
Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis
Alzheimer's Disease: From Pathogenesis to Disease-Modifying Approaches
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Alzheimer%26apos;s disease and epigenetic diet
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Alzheimer's Disease and Environmental Exposure to Lead: The Epidemiologic Evidence and Potential Role of Epigenetics
Alzheimer's disease and anaesthesia: Potential relationships and clinical implications
Alzheimer Center Reina Sofia Foundation: Fighting the Disease and Providing Overall Solutions
Alzheimer's disease: synaptic dysfunction and A beta
Alzheimer Research Series on the Default Network
Alzheimer's Disease: Diagnosis and Treatment Across the Spectrum of Disease Severity
Alzheimer%26apos;s disease markers, hypertension, and gray matter damage in normal elderly
Alzheimer's Disease is Incurable but Preventable
Alzheimer's disease prevalence can be lowered with non-invasive testing
Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: Experimental approaches and future clinical applications
Alzheimer's Disease Biomarkers: More Than Molecular Diagnostics
Alzheimer%26apos;s disease models and functional genomics How many needles are there in the haystack?
Alzheimer%26apos;s disease: pathological mechanisms and the beneficial role of melatonin
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors (vol 7, pg 812, 2008)
Alzheimer's disease Relationship between cognitive aspects and power and coherence EEG measures
Alzheimer's Disease: beta-Amyloid Plaque Formation in Human Brain
Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: Associations and a hypothesis
Alzheimer-type neuropathological changes in morbidly obese elderly individuals
Alzheimer's Disease and Anesthesia: Out of Body, Out of Mind ... or Not?
Alzheimer%26apos;s disease A beta assemblies mediating rapid disruption of synaptic plasticity and memory
Alzheimer's Disease and Intelligence
Alzheimer's Mechanisms in Ischemic Brain Degeneration
Alzheimer%26apos;s disease can spare local metacognition despite global anosognosia: Revisiting the confidence-accuracy relationship in episodic memory
Alzheimer's disease and memory-monitoring impairment: Alzheimer's patients show a monitoring deficit that is greater than their accuracy deficit
Alzheimer's Disease Amyloid beta-Protein Mutations and Deletions That Define Neuronal Binding/Internalization as Early Stage Nonfibrillar/Fibrillar Aggregates and Late Stage Fibrils
Alzheimer's disease Molecular pathology, animal models, and current treatment
Alzheimer's Genetics in the GWAS Era: A Continuing Story of 'Replications and Refutations'
Alzheimer's Disease-Like Pattern of F-18-FDG Uptake during a Hyperglycemic State and Negative C-11-PiB Binding in a Patient with Mild Cognitive Impairment
Alzheimer's disease - The latest suspect
Alzheimer's disease genetics: lessons to improve disease modelling
Alzheimer's disease genetics: current knowledge and future challenges
Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments
Alzheimer's Disease and the "Valley of Death": Not Enough Guidance from Human Brain Tissue?
Alzheimer Disease Susceptibility Loci: Evidence for a Protein Network under Natural Selection
Alzheimer Disease: New Concepts on Its Neurobiology and the Clinical Role Imaging Will Play
Alzheimer%26apos;s and ABC transporters - new opportunities for diagnostics and treatment
Alzheimer's Disease: Emerging Trends in Small Molecule Therapies
Alzheimer's Disease and tauopathy studies in flies and worms
Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified gamma-Secretase Complexes
Alzheimer's disease-related protein hGas7b interferes with kinesin motility
Alzheimer's disease: A search for broken links
Alzheimer disease family history impacts resting state functional connectivity
Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin
Alzheimer Mechanisms and Therapeutic Strategies
Alzheimers disease in a dish: promises and challenges of human stem cell models
Alzheimer's disease and age-related memory decline (preclinical)
Alzheimer Disease and Cellular Mechanisms of Memory Storage
Alzheimer's Disease: The Challenge of the Second Century
Alzheimer%26apos;s disease risk factor lymphocyte-specific protein tyrosine kinase regulates long-term synaptic strengthening, spatial learning and memory